Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
388,917,807
-
Number of holders
-
207
-
Total 13F shares, excl. options
-
349,969,099
-
Shares change
-
+300,430
-
Total reported value, excl. options
-
$1,924,816,425
-
Value change
-
+$2,242,808
-
Put/Call ratio
-
67%
-
Number of buys
-
128
-
Number of sells
-
-95
-
Price
-
$5.50
Significant Holders of LifeStance Health Group, Inc. - Common Stock, par value $0.01 per share (LFST) as of Q3 2025
259 filings reported holding LFST - LifeStance Health Group, Inc. - Common Stock, par value $0.01 per share as of Q3 2025.
LifeStance Health Group, Inc. - Common Stock, par value $0.01 per share (LFST) has 207 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 349,969,099 shares
of 388,917,807 outstanding shares and own 90% of the company stock.
Largest 10 shareholders include TPG GP A, LLC (160,711,618 shares), FMR LLC (38,994,756 shares), SUMMIT PARTNERS L P (33,524,715 shares), BlackRock, Inc. (17,478,046 shares), VANGUARD GROUP INC (14,613,535 shares), DIMENSIONAL FUND ADVISORS LP (8,363,607 shares), JENNISON ASSOCIATES LLC (7,433,270 shares), UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (4,793,336 shares), GEODE CAPITAL MANAGEMENT, LLC (3,962,065 shares), and GOLDMAN SACHS GROUP INC (3,567,353 shares).
This table shows the top 207 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.